Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Meds Apotek AB (publ)FRA:24R +17.68%11 EV-to-FCF is 528.83 as of Jul. 22, 2026, which is 2595% above its 10-year median of 19.62. GuruFocus rates FRA:24R with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 776 Retail - Cyclical companies, Meds Apotek AB (publ) ranks worse than 93.43% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Meds Apotek AB (publ)'s Enterprise Value is €36.49 Mil.
Meds Apotek AB (publ)'s Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was €0.07 Mil. Therefore, Meds Apotek AB (publ)'s EV-to-FCF for today is 528.83.
The historical rank and industry rank for Meds Apotek AB (publ)'s EV-to-FCF or its related term are showing as below:
FRA:24R'
s EV-to-FCF Range Over the Past 10 Years
Min: -88.25 Med: 19.62 Max: 102.49
Current: 102.49
During the past 4 years, the highest EV-to-FCF of Meds Apotek AB (publ) was 102.49. The lowest was -88.25. And the median was 19.62.
FRA:24R's EV-to-FCF is ranked worse than 93.43% of 776
companies
in the Retail - Cyclical industry
Industry Median: 13.68
vs FRA:24R: 102.49
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Meds Apotek AB (publ) (FRA:24R) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Meds Apotek AB (publ)'s PE Ratio (TTM) for today is calculated as:
Meds Apotek AB (publ)'s share price for today is €2.13.
Meds Apotek AB (publ)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.069.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Internet Retail subindustry, Meds Apotek AB (publ)'s EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meds Apotek AB (publ) EV-to-FCF vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Meds Apotek AB (publ)'s EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Meds Apotek AB (publ)'s EV-to-FCF falls into.
Meds Apotek AB (publ)'s current Enterprise Value is €36.49 Mil.
Meds Apotek AB (publ)'s Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.07 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meds Apotek AB (publ) (FRA:24R) has a EV-to-FCF of 528.83 as of Jul. 22, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Meds Apotek AB (publ) and its competitors. This is 2595% above median its historical median of 19.62. According to the industry distribution chart, Meds Apotek AB (publ) ranks #725 out of 776 companies in the Retail - Cyclical industry, placing it in the top 93.4%.
Is Meds Apotek AB (publ)'s EV-to-FCF too high?
Meds Apotek AB (publ)'s current EV-to-FCF of 528.83 is 2595% above median its 10-year median of 19.62. The Retail - Cyclical industry median EV-to-FCF is 13.68. Meds Apotek AB (publ)'s value of 528.83 is 3765.7% above this industry median. Based on the distribution chart, Meds Apotek AB (publ) ranks #725 out of 776 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Meds Apotek AB (publ) has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Meds Apotek AB (publ)'s EV-to-FCF compare to AMZN and BABA?
According to the Retail - Cyclical industry distribution chart, Meds Apotek AB (publ) ranks #725 out of 776 companies for EV-to-FCF. This places Meds Apotek AB (publ) in the lower half of its industry. The industry median EV-to-FCF is 13.68. Meds Apotek AB (publ)'s value of 528.83 is 3765.7% above this benchmark. While the company's 10-year median is 19.62 vs. the industry median of 13.68, Meds Apotek AB (publ) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Retail - Cyclical company?
The median EV-to-FCF among Retail - Cyclical companies is 13.68, based on 776 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Meds Apotek AB (publ)'s current EV-to-FCF of 528.83 is 3765.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Meds Apotek AB (publ) and its competitors. For the Retail - Cyclical industry, the median EV-to-FCF is 13.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Meds Apotek AB (publ)'s current EV-to-FCF is 528.83, which is 2595% above median its own 10-year median of 19.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meds Apotek AB (publ) stock overvalued right now?
Meds Apotek AB (publ) (FRA:24R) has a current EV-to-FCF of 528.83. The current EV-to-FCF is 528.83, which is 2595% above median its 10-year median of 19.62 and 3765.7% above the Retail - Cyclical industry median of 13.68. Meds Apotek AB (publ)'s overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Meds Apotek AB (publ) (FRA:24R), the current EV-to-FCF is 528.83 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Medical Products Agency, the Swedish Food Agency and the E-Health Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty products, children's products, fitness products, food and drink and home & household products.
11GF Score
Get the complete analysis for FRA:24R
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:24R has been successfully added to your 
